Utilization and spending trends for pain medications among cancer survivors in the United States: Results from the Medical Expenditure Panel Survey

• In: Poster presentation
• At: Buenos Aires (Argentina) (2016)
• Type: Poster
• Poster code: POS-SAPS-039
• By: PENM, Jonathan (University of Cincinnati, James L Winkle College of Pharmacy, Cincinnati, United States)
• Co-author(s): Amarsinh Desai:James L Winkle College of Pharmacy,University of Cincinnati,Cincinnati,United States|Christina Kelton:Carl H. Lindner College of Business,University of Cincinnati,Cincinnati,United States|Jill Boone:James L Winkle College of Pharmacy,University of Cincinnati,Cincinnati,United States|Teresa Cavanaugh:James L Winkle College of Pharmacy,University of Cincinnati,Cincinnati,United States|Alex Lin:James L Winkle College of Pharmacy,University of Cincinnati,Cincinnati,United States|Jonathan Penm:James L Winkle College of Pharmacy,University of Cincinnati,Cincinnati,United States|Pamela Heaton:James L Winkle College of Pharmacy,University of Cincinnati,Cincinnati,United States
  
• Abstract:

  Cancer pain, either tumor-related or treatment-related, is common among cancer survivors. 

  Data were obtained from the Medical Expenditure Panel Survey (MEPS) annually from 2008-2013. Cancer survivors, excluding survivors of nonmelanoma skin cancer, were extracted for analysis. 

  Out of 23.4 million cancer survivors in 2008, 40.8% took pain

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login